Thursday Sep 15, 2022

To boost or not to boost – Part 2

This episode continues our discussion on the new bivalent COVID boosters that target the original virus and also Omicron subvariants BA.4 and BA.5.


Guest speaker:
Azra Behlim, PharmD, MBA
Associate Vice President, Pharmacy Sourcing and Program Services


Tomas Villanueva, DO, MBA, FACPE, SFHM
Senior Principal, Clinical Operations and Quality


Show Notes:

[00:30] Is the booster safe?

[00:48] Efficacy

[01:32] How long to wait after previous vaccine

[02:47] Whether or not to get flu vaccines

[05:58] Feasibility of using the booster as an initial vaccine in a series

[07:52] Novavax

[09:05] Nasal vaccines and mucosal immunity


Links | Resources:

To contact Modern Practice:

FDA announcement on new vaccine boosters (8-31-22): Click here


Subscribe Today!

Apple Podcasts

Amazon Podcasts


Google Podcasts



RSS Feed

Copyright 2023 All rights reserved.

Version: 20230822